Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-73,132
Closed -$2.39M 3772
2025
Q4
$2.39M Buy
+73,132
New +$1.8M 0.01% 1191
2025
Q1
Sell
-19,230
Closed -$316K 2514
2024
Q4
$316K Buy
+19,230
New +$272K ﹤0.01% 1685
2024
Q1
Sell
-19,376
Closed -$132K 2309
2023
Q4
$132K Buy
+19,376
New +$108K ﹤0.01% 1859
2023
Q3
Sell
-47,337
Closed -$432K 2390
2023
Q2
$432K Sell
47,337
-10,900
-19% -$102K ﹤0.01% 1440
2023
Q1
$550K Sell
58,237
-56,803
-49% -$520K 0.01% 1297
2022
Q4
$1.15M Buy
115,040
+99,130
+623% +$1.1M 0.02% 871
2022
Q3
$189K Buy
+15,910
New +$159K ﹤0.01% 2232
2022
Q2
Sell
-19,703
Closed -$156K 2916
2022
Q1
$156K Buy
+19,703
New +$170K ﹤0.01% 2550
2021
Q3
Sell
-11,280
Closed -$243K 3267
2021
Q2
$243K Buy
+11,280
New +$228K ﹤0.01% 2279
2020
Q4
Sell
-19,440
Closed -$226K 1842
2020
Q3
$226K Buy
+19,440
New +$226K 0.01% 1299
2018
Q4
Sell
-12,674
Closed -$467K 588
2018
Q3
$467K Buy
+12,674
New +$553K 0.07% 185

Other funds holding AXGN

HRT Financial's AXGN Position: Q1 2026 in Review

HRT Financial sold out of Axogen (AXGN) in Q1 2026, closing a stake of 73,132 shares — an estimated $2.39M sold.

HRT Financial first reported a position in AXGN in Q3 2018 and held it in 11 quarters. The position peaked at $2.39M in Q4 2025. 220 funds tracked by Wall St. Rank hold AXGN as of Q1 2026.

  • HRT Financial reported no remaining Axogen position as of Q1 2026 after selling out during the quarter.
  • HRT Financial sold 73,132 Axogen shares in Q1 2026, an estimated $2.39M.
  • HRT Financial first reported a position in Axogen in Q3 2018 and held it in 11 quarters.
  • HRT Financial's Axogen position peaked at $2.39M in Q4 2025.
  • 220 funds tracked by Wall St. Rank held Axogen as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.